BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23143169)

  • 1. Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors.
    Yoshikawa K; Shimada M; Kurita N; Sato H; Iwata T; Morimoto S; Miyatani T; Kashihara H; Takasu C; Matsumoto N
    Surg Today; 2013 Oct; 43(10):1162-7. PubMed ID: 23143169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
    Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
    Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
    Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET.
    Narushima K; Shuto K; Okazumi S; Ohira G; Mori M; Hayano K; Yanagawa N; Matsubara H
    Sci Rep; 2023 Feb; 13(1):2266. PubMed ID: 36755154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractal analysis of contrast-enhanced CT images for preoperative prediction of malignant potential of gastrointestinal stromal tumor.
    Kurata Y; Hayano K; Ohira G; Narushima K; Aoyagi T; Matsubara H
    Abdom Radiol (NY); 2018 Oct; 43(10):2659-2664. PubMed ID: 29500645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index.
    Kwon Y; Park E; Pahk K; Kim S; Kim MJ; Graf D; Park S
    J Cancer Res Ther; 2019; 15(1):142-147. PubMed ID: 30880770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of preoperative
    Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
    Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.
    Hassanzadeh-Rad A; Yousefifard M; Katal S; Asady H; Fard-Esfahani A; Moghadas Jafari A; Hosseini M
    J Gastroenterol Hepatol; 2016 May; 31(5):929-35. PubMed ID: 26642423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
    J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
    Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
    Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
    World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of
    Li S; Lin D; Tang M; Liu D; Lyu Q; Zhang J
    J Gastrointest Oncol; 2022 Apr; 13(2):637-646. PubMed ID: 35557562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
    Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
    Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group.
    Kalkmann J; Zeile M; Antoch G; Berger F; Diederich S; Dinter D; Fink C; Janka R; Stattaus J;
    Cancer Imaging; 2012 May; 12(1):126-35. PubMed ID: 22572545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
    Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
    World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy.
    Wei K; Pan B; Yang H; Lu C; Ge L; Cao N
    Medicine (Baltimore); 2018 Apr; 97(16):e0389. PubMed ID: 29668594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal gastrointestinal stromal tumor: report of 7 patients.
    Shinagare AB; Zukotynski KA; Krajewski KM; Jagannathan JP; Butrynski J; Hornick JL; Ramaiya NH
    Cancer Imaging; 2012 Apr; 12(1):100-8. PubMed ID: 22542728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.
    Holdsworth CH; Badawi RD; Manola JB; Kijewski MF; Israel DA; Demetri GD; Van den Abbeele AD
    AJR Am J Roentgenol; 2007 Dec; 189(6):W324-30. PubMed ID: 18029844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.